根治性放化疗后挽救性肺切除术:安全有效的肿瘤学选择
BACKGROUND: Patients with locally advanced, non-small cell lung cancer treated with definitive chemoradiotherapy alone often demonstrate persistent or recurrent disease.…
要点
- 严格选择患者下挽救性肺切除可行,R0切除者预后显著更优
- 扩大切除与R1切除与更差生存相关,应尽量实现ypN0R0简单切除
核心结论
- 经过恰当患者选择,根治性放化疗后挽救性肺切除可获可接受的并发症率、死亡率和肿瘤学结局,尤其当通过非扩大手术实现ypN0R0切除时。
主要发现
- 根治性放疗后至手术的中位时间为279天(四分位距168-474天)。
临床怎么用
- 对局部晚期NSCLC根治性放化疗后无全身进展、持续或复发疾病患者,可考虑挽救性肺切除,但需严格选择。
- 术前应评估能否实现ypN0R0非扩大切除,若需扩大切除或预期R1切除,预后较差需谨慎权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with locally advanced, non-small cell lung cancer treated with definitive chemoradiotherapy alone often demonstrate persistent or recurrent disease. In the absence of systemic progression, salvage lung resection after definitive chemoradiotherapy has been used as a treatment option. Given the paucity of data, we sought to evaluate the safety and efficacy of salvage pulmonary resections occurring greater than 90 days after definitive chemoradiotherapy. METHODS: Retrospective institutional database review identified patients undergoing salvage lung resection at least 90 days after the completion of definitive chemoradiotherapy. Primary outcomes evaluated were overall survival and recurrence-free survival. RESULTS: Thirty patients met inclusion criteria between January 1, 2004 and December 31, 2015. Median time to surgery after definitive radiotherapy was 279 days (interquartile range, 168-474 days). Extended resections were performed in 11 patients (37%). Ottawa Thoracic Morbidity and Mortality Classification System grade IIIA or greater complications occurred in 12 patients (40%). Thirty-day mortality was 6.7% (2 patients). Median overall survival after salvage resection was 24 months. Median overall survival for an R1 resection was 5.3 months vs 108 months for an R0 resection (P = .001). Persistent pN1-positive salvage resections also did less well compared with pN0 (8.9 vs 28.2 months; P = .06). For patients who underwent nonextended salvage resection (simple lobectomy or simple pneumonectomy), median overall survival was 108.4 months, vs 8.9 months for extended salvage resections (P = .02). CONCLUSIONS: With proper patient selection, salvage lung resections can be performed with acceptable morbidity, mortality, and oncologic outcomes, particularly when a ypN0R0 resection can be achieved by nonextended surgical means.
引用
- Bograd AJ, Mann C, Gorden JA, et al. Salvage Lung Resections After Definitive Chemoradiotherapy: A Safe and Effective Oncologic Option. Ann Thorac Surg. 2020. PMID: 32473131. doi:10.1016/j.athoracsur.2020.04.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。